Netherlands· NL-510c4c0a78b5

Etonogestrel/Ethinylestradiol Exeltis 0,120 mg/0,015 mg per 24 uur, hulpmiddel voor vaginaal gebruik

A vaginalring mit gestagenen und estrogenen product containing ethinylestradiol + etonogestrel, registered in Netherlands by Exeltis Healthcare S.L. The same ATC class is registered in 10 of our 19 countries.

ATC G02BB01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about ethinylestradiol + etonogestrelAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Vaginalring mit gestagenen und estrogenen is registered in 10 of 19 countries.

Countries holding a registration under ATC G02BB01 (vaginalring mit gestagenen und estrogenen), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
7 of them publish a price we can compare per daily dose

Search vaginalring mit gestagenen und estrogenen products by name

Vaginalring mit gestagenen und estrogenen · ATC G02BB01

10 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: ETHINYLESTRADIOL + ETONOGESTREL
Manufacturer: Exeltis Healthcare S.L
Country: Netherlands (NL)
ATC code: G02BB01
ATC class: Vaginalring mit Gestagenen und Estrogenen
Defined daily dose: 0.0357 DE, V
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
118996

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for vaginalring mit gestagenen und estrogenen.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check vaginalring mit gestagenen und estrogenen against other medicines How interaction checks work

Vaginalring mit gestagenen und estrogenen · interactions on record

3 records

3 more interactions with mechanism and management, from a commercially licensed source.

Mechanism and what to do, in the interaction check

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Vaginalring mit gestagenen und estrogenen in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vaginalring mit gestagenen und estrogenen products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Femloop Vaginalring, Ginoring Vaginalring
Belgium · Circlet, Etonogestrel/ Ethinylestradiol Laboratorios Leon Farma
Czechia · Nuvaring, Ornibel
Germany · Adalina, Circlet
Denmark · Nuvaring, Ornibel
Estonia · Nuvaring, Ornique
Spain · Circlet, Dolna
Finland · Nuvaring, Ornibel
France · Ethinylestradiol/Etonogestrel Biogaran, Ethinylestradiol/Etonogestrel Ccd
United Kingdom (Northern Ireland) · Nuvaring, Syreniring
Greece · Nuvaring
Hungary · Femiring, Ladeering
Ireland · Nuvaring
Iceland · Nuvaring, Ornibel
Italy · Archegan, Myprimose
Lithuania · Nuvaring, Ornique
Luxembourg · Circlet, Etonogestrel / Ethinylestradiol Laboratorios Leon Farma
Latvia · Nuvaring, Ornique
Malta · Nuvaring, Teyla
Norway · Nuvaring, Ornibel
Poland · Adaring, Ginoring
Portugal · Anette, Circlet
Romania · Nuvaring
Sweden · Nuvaring, Ornibel
Slovenia · Nuvaring
Slovakia · Nuvaring, Ornibel

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/b3e443eb-e1e7-4613-b88b-1c6d21effffe
GET /v1/drugs/b3e443eb-e1e7-4613-b88b-1c6d21effffe?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Hulpmiddel voor vaginaal gebruik",
  "route": "Vaginaal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h118996_smpc_en.pdf",
  "strength": null,
  "atc_label": "Vaginal Ring With Progestogen And Estrogen",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg118996",
  "excipients": [
    "COPOLYMEER VAN ETHYLEEN-VINYLACETAAT (28 pCt. vinylacetaat)",
    "POLYURETAAN"
  ],
  "substances": [
    "ETHINYLESTRADIOL",
    "ETONOGESTREL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h118996_piluk.pdf",
  "authorised_at": "2017/09/11",
  "procedure_number": "NL/H/3719/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "118996",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about vaginalring mit gestagenen und estrogenen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console